ARTICLE | Clinical News
BSD-2000: Phase III started
February 15, 2010 8:00 AM UTC
BSD began an international Phase III trial to evaluate gemcitabine with or without the BSD-2000 Hyperthermia System in pancreatic cancer patients with surgical tumor resection. ...